Jake’s mother, Stephanie, describes her son as a beautiful, bright 14-year old boy. In late 2011, he was diagnosed with Asperger’s syndrome in an extremely mild form (the diagnosis of Asperger’s was eliminated in 2013 in DSM-5 and replaced by a diagnosis of autism spectrum disorder).

Jake started counselling with a psychologist in 2011 due to some dark thoughts that had appeared in an essay he wrote in school. In January 2013, he had counselling again, for anxiety, and his psychologist decided to refer him to her colleague, a psychiatrist, as she felt his anxiety would be heightened when he was to sit his state exams. Jake’s parents didn’t even know what a psychiatrist was but just thought it was the psychologist’s colleague.

Jake’s dad took him to his appointment because no big deal was made of it, and they met with the psychiatrist for ten minutes, after which they left with a prescription for fluoxetine. Jake had never been on medication before, but the family was not given any literature or any description from the psychiatrist or the pharmacist, and they didn’t even know what sort of drug Prozac was but simply trusted the psychiatrist.

Six days later, Jake had his first reaction. He walked out of an exam half-way through it and cried for about 2-3 hours that night, saying, “You don’t know what it’s like in my head.” His parents thought this was from the stress of the exams. They never imagined that a drug could do this to a person.

About a week later, they got Jake back to the psychiatrist and told her all about what happened, but she said that it would wear off after three or four weeks and that Jake would be fine. But Jake was not fine, and on day 46 he was a bit restless after school and looked a bit flush in the face, although he never had a colour in his cheeks. His parents thought he had a row with his little online girlfriend.

The family had a legally held rifle in the house, as Jake and Stephanie were members of a shooting club. They would often take the gun down, and Jake asked if he could take it down that night, which was nothing out of the ordinary, so his request was granted. Stephanie forgot to take the box from his room with bolt and ammunition.

Jake placed the gun in his mouth and pulled the trigger. He had no history of suicide ideation or self-harm, and no diagnosis of anything but Asperger’s. However, the National Health Service in Ireland is now trying to say he had severe anxiety – although this isn’t true – and it fights the parents from every corner with this. It is the same story all the time: put all the blame on the disease, never on the drug. The parents asked David Healy to do a second opinion based on Jake’s medical files, which he did.

Stephanie and her husband have attended their son’s inquest three times so far and are still in the middle of a legal argument about which medical expert the Coroner’s court will allow them to consult. The court has refused their request to use David Healy, as he is considered to be not impartial due to his papers and books about the relation between SSRIs and suicide!

Stephanie finds the whole thing absolutely disgusting. This was a 14-year old child who had plans for the future. He had no illness, he had a condition that no medication would fix, and he was living quite happily with just counselling for his anxiety. Stephanie and her husband were never told about the dangers of drugs like fluoxetine. Had they known about them, they would never have kept a firearm in the house. 

(First published in my book, Deadly Psychiatry and Organised Denial)

Maria Bradshaw’s son Toran who was her only child was prescribed fluoxetine in January 2007 despite having been assessed as being a healthy adolescent who had an expected reaction to a stressful life event, which was a breakup with his girlfriend. A month later, Toran experienced a severe cluster of adverse reactions including suicidal behaviour, self-harm, aggression, hostility, hallucinations, lack of concentration and impaired functioning. The symptoms were so severe that he dropped out of school. His psychiatrist’s response was to increase his dose, which worsened the adverse reactions. Toran withdrew from fluoxetine and from mental health treatment of his own volition.

The following year, a psychiatric registrar prescribed fluoxetine to him again, against his mother’s wishes. The registrar recorded no diagnosis after having conducted a mental state exam and finding no evidence of depression, anxiety or any other mental disorder. The next day, a multi-disciplinary team reviewed Toran’s file and recorded “diagnosis deferred” noting that there was no evidence of a mental disorder. Toran initially refused the prescription on the basis that fluoxetine should not be taken with alcohol, but the registrar recorded that he had reached an agreement with Toran that he would stop taking the fluoxetine on a Friday, could drink up to six bottles of beer a night over the weekend and restart his fluoxetine on Mondays. Given fluoxetine’s long half-life in the body, 2 to 4 days for the drug and 7 to 15 days for its active metabolite norfluoxetine, this was a foolish recommendation. Toran followed this regime but suffered a repeat of the former adverse reactions and suddenly hanged himself after 15 days on fluoxetine. He was only 17 years old.

After Toran’s death, Maria had genetic testing conducted, which confirmed that Toran metabolised drugs slowly and had therefore been overdosed. Maria also established CASPER, an organisation where those bereaved by suicide help others bereaved by suicide (http://www.casper.org.nz/). Maria has told me that the national media have credited CASPER with a 20% drop in youth suicide and that it means more to her than anything else that her son continues to do good in the world despite not being here physically.

Maria wrote to the District Health Boards in New Zealand and found out that 8% of those who died and who had gotten a recent prescription for an antidepressant, had no diagnosis of any mental disorder. In the district responsible for Toran’s care, 75% of those under 18 who died had no diagnosis.

In New Zealand, psychiatrists and suicidologists have managed to convince the government that publishing information on suicides causes copycat suicide. She has reviewed the evidence for this, which is extremely weak, but it’s nonetheless a criminal offense for Maria to tell Toran’s story, punishable by a fine of up to $5,000 each time and a fine for the media of up to $20,000. These threats have not stopped Maria and she has had support from the media.

Maria sold her home to pay for Toran’s inquest when the doctors dragged it out over 18 days of hearings, thinking she would walk away because of the cost. She now lives in Dublin, in the home of another mother who lost her child to SSRI-induced suicide, Leonie Fennell, and has everything she owns in two suitcases.

There have been ten government enquiries into Toran’s death but, as in all such cases, the issue is not whether the child received a good standard of care but whether the psychiatrist departed from generally accepted practice. And of course, since the usual practice in psychiatry is terribly poor, most of the investigations found that Toran’s care was not a departure from usual practice. However, both the government and Mylan Pharmaceuticals have resolved that it is probable that fluoxetine caused Toran’s suicide.

Maria is still fighting to achieve justice and has persuaded the police to review Toran’s file to see whether manslaughter charges can be laid. She hopes that her efforts will be a deterrent, which could make other doctors consider that their patients may have a stroppy mother like her and be more careful. Maria has spent seven years on meticulously documenting Toran’s case learning everything she could about psychopharmacology, psychiatry, neurochemistry, genetics, randomised trials and anything else that could help not only her but also all the other parents that have stories similar to hers.

When I gave a lecture at the Department of Psychology at the Manooth University outside Dublin, to which Maria had invited me, another bereaved mother was in the audience, Stephanie McGill Lynch, who also lost her child to fluoxetine. Maria wrote to me:

“I know you agree with me that this has got to stop.” Yes, and this is why I have written this book. I won’t accept that doctors and drug companies push our children into suicide with drugs that have no benefits for them. I cannot see it’s any different to killing our children by pushing narcotic drugs in the street.

(First published in my book, Deadly Psychiatry and Organised Denial)

Danilo Terrida was only 20 when he hanged himself in a crane at a shipyard in 2011, two hours after having assured his family on the phone that he was fine and had small-talked with them. A month earlier, he had celebrated his birthday and everything apparently went well. Two weeks later, he made contact with the emergency medical service because he did not feel well psychologically and was sent home with tranquillising pills and was advised to see a doctor the next day. The local doctor he contacted refused to see him and asked him to call his family doctor several hundred kilometres away. This he did, and after eight minutes on the phone, he was prescribed sertraline, although he wasn’t depressed, and with no follow-up. A few moments before he killed himself, Danilo talked to a friend and said he didn’t know what was happening to him, but he didn’t mention anything about suicide. This is rather typical of an SSRI-induced suicide, and the timing is also typical. Many people kill themselves early on. The involved doctors have been officially criticised for amending Danilo’s files, up to a year after his death, so that it looked more plausible that he killed himself because of a depression, which wasn’t true (see www.daniloforlivet.dk).

At least 11 other people, 10 of them adults, who have committed suicide in Denmark on antidepressants have acquired economic compensation from the Patient Insurance Association.

(First published in my book, Deadly Psychiatry and Organised Denial)

The FDA issued a black box warning about antidepressants in 2004, updated in 2006, about “Increased risk of suicidal thinking and behavior in children, adolescents, and young adults.”

It is far worse than this. Depression pills double not only the risk of suicide, and not only in young people, but also suicides (1-4).

Despite the convincing facts, derived from placebo-controlled randomised trials, leading professors of psychiatry in the whole world continue to lie, claiming that these drugs protect against suicide (5,6). And as guidelines and so-called suicide experts continue recommending depression drugs for people at risk of suicide (5), it is not surprising that suicide prevention programmes all over the world have increased suicides (7,8).

This is a betrayal so deep, particularly considering that psychotherapy can halve the risk of new suicide attempts in high-risk patients, those admitted to hospital after a suicide attempt (9), that we must do our utmost to warn patients against accepting treatment with depression drugs, which, moreover, do not have any meaningful effects in depression (1,2,5).

I shall therefore republish patient stories on this website. When I launched my first psychiatry book (1) at a meeting in Copenhagen in 2015, five of the involved women heard about it and came at their own expense to talk about their losses. There was total silence while they recounted their shocking stories, which I have uploaded (10).

1 Gøtzsche PC. Deadly psychiatry and organised denial. Copenhagen: People’s Press; 2015.

2 Gøtzsche PC, Healy D. Restoring the two pivotal fluoxetine trials in children and adolescents with depression. Int J Risk Saf Med 2022;33:385-408. Full article available here.

3 Hengartner MP, Plöderl M. Newer-generation antidepressants and suicide risk in randomized controlled trials: a re-analysis of the FDA database. Psychother Psychosom 2019;88:247-8.

4 Hengartner MP, Plöderl M. Reply to the Letter to the Editor: “Newer-Generation Antidepressants and Suicide Risk: Thoughts on Hengartner and Plöderl’s ReAnalysis.” Psychother Psychosom 2019;88:373-4.

5 Gøtzsche PC. Is psychiatry a crime against humanity? Copenhagen: Institute for Scientific Freedom; 2024 (freely available).

6 Gøtzsche PC. Usage of depression pills almost halved among children in Denmark. Mad in America 2018; May 4.

7 Whitaker R. Suicide in the age of Prozac. Mad in America 2018; Aug 6.

8 Whitaker R, Blumke D. Screening + drug treatment = increase in veteran suicides. Mad in America 2019; Nov 10.

9 Gøtzsche PC, Gøtzsche PK. Cognitive behavioural therapy halves the risk of repeated suicide attempts: systematic review. J R Soc Med 2017;110:404-10.

10 Videos from International meeting: Psychiatric drugs do more harm than good. Copenhagen 2015; Sept 16.

This little article is a copy of a section in my autobiography, Whistleblower in healthcare, which can be downloaded for free here: https://www.scientificfreedom.dk/books/. It describes how both GSK, AstraZeneca and Cochrane committed fraud, to the benefit of their steroid, but it doesn’t work and is actually harmful. Read article here

Depression drugs are ineffective for all degrees of depression and they double the risk of suicide whereas psychotherapy halves the risk of suicide. Guidelines for treating depression need to be urgently changed. Read article

When Trump nominated Robert F Kennedy Jr. as upcoming health secretary and Marty Makary as new FDA commissioner, the legacy media went berserk. Instead of describing what is wrong with healthcare and the widespread corruption at the FDA, the media attempted character assassination on both Kennedy and Makary. Read article

The psychiatric system is so sick that it punishes those who go against the grain and get better results than their colleagues by using less force and drugging less. In Denmark, a chief psychiatrist opened a force-free department, and they had available beds, in contrast to all other departments that scream: Send more money. He was fired and has even been reported to the police. The patients and relatives smell blood, too, in the form of cool cash because it is alleged that he did something wrong. I suspect he is the victim of a witch hunt and have argued that if the patient files at other departments were examined, the professional standard would likely be lower than at his department. Read my article.

As the most meaningful titles have already been taken by reputable journals, titles for predatory journals are often a meaningless hodgepodge of words. I present here an analysis of the logical structure of some of the weirdest journal titles in invitations I received during January and February 2025, e.g. Journal of Nutrition and Health Sciences is like Journal of Diabetes and Everything Else. Read article.

In 2008, I was exposed to absurd censorship and editorial misconduct when I tried to publish a Cochrane review of an obscenely expensive drug, alpha-1 antitrypsin for patients with lung disease caused by inherited alpha-1 antitrypsin deficiency. I have also been exposed to censorship in relation to our assessment of the quality of 53 new Cochrane reviews, mammography screening, house dust mites, antidepressants, and most recently, in February 2025, in relation to our update of the mammography screening review. Cochrane has fallen so deep now that it seems to be beyond repair. Read my article.